Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 11834507

Anti-MET agonist antibody for use in the treatment of colorectal cancer

AGOMAB THERAPEUTICS · Granted Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11833160

Ursodeoxycholic acid derivatives as HDAC inhibitors for the treatment of polycystic diseas

UNIVERSIDAD DEL PAÍS VASCO / EUSKAL HERRIKO UNIBERTSITATEA · Granted Tue Dec 05 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 30 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11826321

Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and n

TONIX PHARMA LIMITED · Granted Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11826327

Treatment for interstitial lung disease

United Therapeutics Corporation · Granted Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11826339

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11826373

Methods for treatment of diseases

Galera Labs, LLC · Granted Tue Nov 28 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11820982

Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors

REGENERON PHARMACEUTICALS, INC. · Granted Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11819573

Treatment of hip pain with sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. · Granted Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11819523

Compositions and methods for C. difficile treatment

Regents of the University of Minnesota · Granted Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11819572

Treatment of pain by administration of sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. · Granted Tue Nov 21 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 16 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11813357

Treatment of hip pain with sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. · Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11813282

Injectable scaffold for treatment of intracranial aneurysms and related technology

Covidien LP · Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11814622

OPA1 antisense oligomers for treatment of conditions and diseases

STOKE THERAPEUTICS, INC. · Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11806336

Methods and compositions for treatment of epileptic disorders

OVID THERAPEUTICS INC. · Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11806406

Virus-like particle conjugates for diagnosis and treatment of tumors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11806334

Non-sedating dexmedetomidine treatment regimens

BioXcel Therapeutics, Inc. · Granted Tue Nov 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11802131

Glutarimides for medical treatment

C4 THERAPEUTICS, INC. · Granted Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11801313

Materials and methods for treatment of pain related disorders

Vertex Pharmaceuticals Incorporated · Granted Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11801265

Preparation method of NK cells and use thereof in the treatment of cancer

SINO UNITED (BEIJING) BIOMEDICAL TECHNOLOGY CO., LTD. · Granted Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11801288

Cancer vaccines and methods of treatment using the same

Inovio Pharmaceuticals, Inc. · Granted Tue Oct 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11795216

Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as anal

Takeda Pharmaceutical Company Limited · Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11795457

Compositions and methods for treatment of Friedreich's Ataxia

The Board of Regents of the University of Texas System · Granted Tue Oct 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11786508

Use of sublingual dexmedetomidine for the treatment of agitation

BioXcel Therapeutics, Inc. · Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11786517

Methods of treatment using a JAK inhibitor compound

Theravance Biopharma R&D IP, LLC · Granted Tue Oct 17 2023 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted